Private investment round-up: August 2008
This article was originally published in Scrip
Executive Summary
As the value of the dollar rose last month, investment in US private pharmaceutical and biotech companies fell sharply by 36% to $99.4 million compared with last month. The total number of companies that secured funding fell by 19% to $175.2 million, a Scrip analysis has found.